China Center for Health Development Studies, Peking University, Beijing, China.
School of Public Health, Peking University, Beijing, China.
BMJ Open. 2022 Sep 28;12(9):e056422. doi: 10.1136/bmjopen-2021-056422.
Depression is becoming a growing cause of disability, suicides and disease burden. It incurred substantial costs to societies all over the world. Estimating the medical costs of depression will provide implications for related policies and interventions. However, there is scarce of evidence on the economic costs of depression in China. The aim of this study is to assess depression-related medical service utilisation, the direct medical costs of depression and potential associated factors.
This study used data that comprised 5% random sample of claims data from China's Urban Basic Medical Insurance between January 2013 and December 2016. Beneficiaries' demographic information, diagnoses and cost of outpatient and inpatient services were recorded in the data set.
26 123 patients with depression were identified as the study population in this study.
The information on health service utilisation and cost was extracted based on the condition that depression was claimed as the index disease.
From 2013 to 2016, weighted average annual total medical cost of depression in urban China was RMB2706.92, and the annual out-of-pocket cost was RMB786.4. The annual total medical cost of depression among urban residents in China was estimated to be 4.4 billion RMB (95% CI 4.15 to 4.67) (US$ 0.70, 95% CI 0.66 to 0.74). Nearly 65% of medical costs (RMB 1795.7 or US$ 285.0) were accounted by inpatient expenditure, and tertiary hospitals were the main provider of depression treatment. Depression-related medical care utilisation and direct costs were associated with gender, age, insurance status, severity of depression and diagnosis. Medication costs and medical service contributed to 41.7% and 56.6% of the average depression-related medical costs.
Depression poses a considerable burden on both the health system and the individual in urban China. Specific policies to strengthen the mental health resources in primary and secondary hospitals are in urgent need, and effective treatment strategies are important to prevent a progression and recurrence of depression, as well as an increase in medical cost.
抑郁症正成为导致残疾、自杀和疾病负担的日益严重的原因。它给全世界的社会造成了巨大的成本。估计抑郁症的医疗费用将为相关政策和干预措施提供依据。然而,中国关于抑郁症经济成本的证据很少。本研究旨在评估与抑郁症相关的医疗服务利用、抑郁症的直接医疗费用以及潜在的相关因素。
本研究使用的数据来自中国城镇基本医疗保险 2013 年 1 月至 2016 年 12 月的 5%随机抽样的索赔数据。该数据集记录了受益人的人口统计学信息、诊断和门诊及住院服务的费用。
本研究共纳入 26123 例抑郁症患者作为研究人群。
根据将抑郁症作为索引疾病的条件,提取了有关卫生服务利用和费用的信息。
2013 年至 2016 年,中国城镇抑郁症患者加权平均年总医疗费用为人民币 2706.92 元,年自付费用为人民币 786.4 元。预计中国城镇居民抑郁症年总医疗费用为人民币 44 亿元(95%置信区间 41.5 亿至 46.7 亿)(0.70 亿美元,95%置信区间 0.66 亿至 0.74 亿美元)。近 65%的医疗费用(人民币 1795.7 元或 0.2850 亿美元)由住院支出,三级医院是治疗抑郁症的主要医疗机构。抑郁症相关医疗保健的利用和直接成本与性别、年龄、保险状况、抑郁症严重程度和诊断有关。药物治疗费用和医疗服务分别占平均抑郁症相关医疗费用的 41.7%和 56.6%。
抑郁症给中国城市的卫生系统和个人都带来了相当大的负担。迫切需要制定加强基层和二级医院精神卫生资源的具体政策,采取有效的治疗策略,防止抑郁症的发展和复发,以及医疗费用的增加。